Get started
Award

ZR2021LZY015

Funded outputs count: 38
Funder award ID: ZR2021LZY015
OpenAlex ID: G19981158
Hedyotis diffusa Willd-Scutellaria barbata herbal pair suppresses triple-negative breast cancer metastasis by targeting the tumor-associated macrophage-driven OPN-CD44 signaling axis
2026 · Yubao Zhang, Yiran Liu, et al. · Phytomedicine · 1
Antigen-presenting CAFs orchestrate immunosuppressive niches via CXCL13-mediated immune cell infiltration dysregulation and prognostic stratification in triple-negative breast cancer
2025 · Jinying Tian, Ye Li, et al. · International Immunopharmacology · 6
The integrated single-cell analysis interpret the lactate metabolism-driven immune suppression in triple-negative breast cancer
2025 · Xinhai Gao, Tianhua Wang, et al. · Discover Oncology · 4
Tubeimoside I inhibits the growth of triple-negative breast cancer via the NR3 C2/PI3 K/AKT signaling pathway
2025 · Qinxiang Zhang, Wenjin Cheng, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1
Genetic association of lipids and lipid-lowering drug target genes with breast cancer
2025 · Tianhua Wang, Yan Yao, et al. · Discover Oncology · 1
Elucidating the Role of Estrogen Effects in Leukemia: Insights from Single-Cell RNA Sequencing and Mendelian Randomization
2024 · Jiahan Zhao, Yang Yu, et al. · Journal of Cancer · 1
PDF
Probing the biological efficacy and mechanistic pathways of natural compounds in breast cancer therapy via the Hedgehog signaling pathway
2024 · Yining Cheng, Wenfeng Zhang, et al. · Journal of Pharmaceutical Analysis · 2
Interactions between hedgehog signaling pathway and the complex tumor microenvironment in breast cancer: current knowledge and therapeutic promises
2024 · Ruijuan Liu, Yang Yu, et al. · Cell Communication and Signaling · 33
PDF
Paris saponin VII inhibits triple-negative breast cancer by targeting the MEK/ERK/STMN1 signaling axis
2024 · Yubao Zhang, Shijie Wei, et al. · Phytomedicine · 22
Elucidation of clinical implications Arising from circadian rhythm and insights into the tumor immune landscape in breast cancer
2024 · Chunjie Sun, Hanyun Zhang, et al. · Heliyon · 7
T cell senescence: a new perspective on immunotherapy in lung cancer
2024 · Mengge Huang, Yuetong Wang, et al. · Frontiers in Immunology · 37
PDF
Galectin-9 in cancer therapy: from immune checkpoint ligand to promising therapeutic target
2024 · Minpu Zhang, Cun Liu, et al. · Frontiers in Cell and Developmental Biology · 34
PDF
Reprogramming of Lipid Metabolism Mediates Crosstalk, Remodeling, and Intervention of Microenvironment Components in Breast Cancer
2024 · Jia Wang, Wenfeng Zhang, et al. · International Journal of Biological Sciences · 42
PDF
Evaluation of Risk Factors, and Development and Validation of Prognostic Prediction Models for Distant Metastasis in Patients With Rectal Cancer: A Study Based on the SEER Database and a Chinese Population
2024 · Huiru Zhang, Haojun Wang, et al. · Cancer Control · 1
Polysaccharides regulate Th1/Th2 balance: A new strategy for tumor immunotherapy
2023 · Qihang Shang, Xiaoyun Yu, et al. · Biomedicine & Pharmacotherapy · 137
Crosstalk and plasticity driving between cancer-associated fibroblasts and tumor microenvironment: significance of breast cancer metastasis
2023 · Wenfeng Zhang, Jia Wang, et al. · Journal of Translational Medicine · 38
PDF
Potential of natural flavonoids to target breast cancer angiogenesis (review)
2023 · Yuetong Wang, Mengge Huang, et al. · British Journal of Pharmacology · 15
Microenvironmental regulation in tumor progression: Interactions between cancer-associated fibroblasts and immune cells
2023 · Dandan Gao, Liguang Fang, et al. · Biomedicine & Pharmacotherapy · 53
Subverted macrophages in the triple-negative breast cancer ecosystem
2023 · Linxiao Shang, Yuting Zhong, et al. · Biomedicine & Pharmacotherapy · 19
MAT as a promising therapeutic strategy against triple-negative breast cancer via inhibiting PI3K/AKT pathway
2023 · Shijie Wei, Yubao Zhang, et al. · Scientific Reports · 13
PDF
ncRNA-mediated ceRNA regulatory network: Transcriptomic insights into breast cancer progression and treatment strategies
2023 · Shu Yang, Xiaomin Wang, et al. · Biomedicine & Pharmacotherapy · 75
NF-κB inhibitors gifted by nature: The anticancer promise of polyphenol compounds
2022 · Chengcheng Guan, Xintong Zhou, et al. · Biomedicine & Pharmacotherapy · 75
PDF
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy
2022 · Qi Liu, Chengcheng Guan, et al. · Biomedicine & Pharmacotherapy · 83
PDF
Post-Translational Modifications of cGAS-STING: A Critical Switch for Immune Regulation
2022 · Yang Yu, Jingyang Liu, et al. · Cells · 58
PDF
Epigenetic modifications: Critical participants of the PD‑L1 regulatory mechanism in solid tumors (Review)
2022 · Xiaoran Ma, Jibiao Wu, et al. · International Journal of Oncology · 25
PDF
Year
Topic